Welcome!

News Feed Item

Mania Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 5, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Mania Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02256138/Mania-Global-Clinical-Trials-Review-H2-2014.html

Mania Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Mania Global Clinical Trials Review, H2, 2014" provides data on the Mania clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mania. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mania. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6

Mania 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Mania to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Mania to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Mania 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Mania Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
AstraZeneca PLC 32

Clinical Trial Overview of AstraZeneca PLC 32
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Abbott Laboratories 35
Clinical Trial Overview of Abbott Laboratories 35
Johnson & Johnson 36
Clinical Trial Overview of Johnson & Johnson 36
Otsuka Holdings Co., Ltd. 37
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 37
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Richter Gedeon Nyrt. 39

Clinical Trial Overview of Richter Gedeon Nyrt. 39
Actavis plc 40
Clinical Trial Overview of Actavis plc 40
Bristol-Myers Squibb Company 41
Clinical Trial Overview of Bristol-Myers Squibb Company 41
Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Top Institutes / Government 43
Massachusetts General Hospital 43
Clinical Trial Overview of Massachusetts General Hospital 43
University of Cincinnati 44
Clinical Trial Overview of University of Cincinnati 44
Mclean Hospital 45
Clinical Trial Overview of Mclean Hospital 45
University of Leipzig 46

Clinical Trial Overview of University of Leipzig 46
Cedars-Sinai Medical Center 47
Clinical Trial Overview of Cedars-Sinai Medical Center 47
University of British Columbia 48
Clinical Trial Overview of University of British Columbia 48
Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 49
National Institute of Mental Health 50
Clinical Trial Overview of National Institute of Mental Health 50
University of Texas Southwestern Medical Center at Dallas 51
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 51
Mashhad University of Medical Sciences 52
Clinical Trial Overview of Mashhad University of Medical Sciences 52
Five Key Clinical Profiles 53
Appendix 114
Abbreviations 114
Definitions 114
Research Methodology 115
Secondary Research 115
About GlobalData 116
Contact Us 116
Disclaimer 116
Source 116

List of Tables

Mania Therapeutics, Global, Clinical Trials by Region, 2014* 7
Mania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mania Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Mania Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Mania Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Mania Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Mania Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Mania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mania Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mania Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Mania Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Mania Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

Mania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mania Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Mania Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Mania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Mania Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Mania Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Mania Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Mania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 32
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 35
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 36
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 37

Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 38
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Richter Gedeon Nyrt., 2014* 39
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 40
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 41
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014* 42
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 43
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2014* 44
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Mclean Hospital, 2014* 45
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2014* 46
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2014* 47
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 48

Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 49
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 50
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 51
Mania Therapeutics Clinical Trials Market, Global, Clinical Trials by Mashhad University of Medical Sciences, 2014* 52

List of Figures

Mania Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Mania Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Mania Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Mania Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Mania Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Mania Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Mania Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Mania Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Mania to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Mania Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Mania Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Mania to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Mania Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Mania Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Mania Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Mania Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Mania Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Mania Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Mania Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Mania Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Mania Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Mania Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Mania Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 115

To order this report: Mania Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02256138/Mania-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Continuous Delivery makes it possible to exploit findings of cognitive psychology and neuroscience to increase the productivity and happiness of our teams. In his session at 22nd Cloud Expo | DXWorld Expo, Daniel Jones, CTO of EngineerBetter, will answer: How can we improve willpower and decrease technical debt? Is the present bias real? How can we turn it to our advantage? Can you increase a team’s effective IQ? How do DevOps & Product Teams increase empathy, and what impact does empath...
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Evatronix will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Evatronix SA offers comprehensive solutions in the design and implementation of electronic systems, in CAD / CAM deployment, and also is a designer and manufacturer of advanced 3D scanners for professional applications.
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to close th...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, discussed how given the magnitude of today's application ...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
You know you need the cloud, but you're hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You're looking at private cloud solutions based on hyperconverged infrastructure, but you're concerned with the limits inherent in those technologies. What do you do?
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
Sanjeev Sharma Joins June 5-7, 2018 @DevOpsSummit at @Cloud Expo New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...